MRx-4DP0004
MRx-4DP0004-II-001
Phase 2 small_molecule terminated
Quick answer
MRx-4DP0004 for COVID-19 is a Phase 2 program (small_molecule) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- 4D Molecular Therapeutics
- Indication
- COVID-19
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated